Conditions: Chronic Hepatitis C
Keywords: Genotype 2
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 10
Healthy volunteers: no

Brief summary:
This study will evaluate the efficacy and safety of MP-424 with Peginterferon Alfa-2b and Ribavirin (RBV) in patients with genotype 2 hepatitis C, who did not respond to previous treatment.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: MP-424 (generic name:Telaprevir) intervention 2: Ribavirin intervention 3: Peginterferon alfa-2b
Intervention descriptions: intervention 1: 750mg q8h for 12 weeks intervention 2: 400 - 1000 mg/day based on body weight for 24 weeks intervention 3: 1.5mcg/kg/week for 24 weeks

Protocol document: